Analysed PROMIS NEUROSCIENCES INC (PMN:NASDAQ) News Sources
ProMIS Neurosciences Invited to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
13-04-2026
yahoo.com
ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights
25-03-2026
yahoo.com
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
18-03-2026
yahoo.com
Five US Stocks See Over $185M in Insider Buying, with Soho House and WR Berkley Leading the Pack
09-02-2026
247wallst.com
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
04-02-2026
yahoo.com
An Intrinsic Calculation For Phoenix Mecano AG (VTX:PMN) Suggests It's 44% Undervalued
18-01-2026
yahoo.com
Phoenix Mecano (VTX:PMN) shareholders have earned a 15% CAGR over the last three years
01-01-2026
yahoo.com
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
18-12-2025
yahoo.com
What is the current price of PROMIS NEUROSCIENCES INC (PMN:NASDAQ)?
The current price of PROMIS NEUROSCIENCES INC (PMN:NASDAQ) is $12.3.
PROMIS NEUROSCIENCES INC (PMN:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROMIS NEUROSCIENCES INC (PMN:NASDAQ) since the previous trading day is $0.25.
PROMIS NEUROSCIENCES INC (PMN:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROMIS NEUROSCIENCES INC (PMN:NASDAQ) since the previous trading day is 2.0747%.
What is the most recent average sentiment score for PROMIS NEUROSCIENCES INC (PMN:NASDAQ)?
The most recent average sentiment score for PROMIS NEUROSCIENCES INC (PMN:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for PROMIS NEUROSCIENCES INC (PMN:NASDAQ)?
The most recent sentiment for PROMIS NEUROSCIENCES INC (PMN:NASDAQ) is .
SEC-8K** Filing Available For PROMIS NEUROSCIENCES INC (PMN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.